244 related articles for article (PubMed ID: 28228148)
21. Prophylactic Melatonin for Delirium in Intensive Care (Pro-MEDIC): study protocol for a randomised controlled trial.
Martinez FE; Anstey M; Ford A; Roberts B; Hardie M; Palmer R; Choo L; Hillman D; Hensley M; Kelty E; Murray K; Singh B; Wibrow B
Trials; 2017 Jan; 18(1):4. PubMed ID: 28061873
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of melatonin for sleep disturbance following traumatic brain injury: a randomised controlled trial.
Grima NA; Rajaratnam SMW; Mansfield D; Sletten TL; Spitz G; Ponsford JL
BMC Med; 2018 Jan; 16(1):8. PubMed ID: 29347988
[TBL] [Abstract][Full Text] [Related]
23. Morning light therapy for juvenile depression and severe mood dysregulation: study protocol for a randomized controlled trial.
Bogen S; Legenbauer T; Bogen T; Gest S; Jensch T; Schneider S; Holtmann M
Trials; 2013 Jun; 14():178. PubMed ID: 23773310
[TBL] [Abstract][Full Text] [Related]
24. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease.
Singer C; Tractenberg RE; Kaye J; Schafer K; Gamst A; Grundman M; Thomas R; Thal LJ;
Sleep; 2003 Nov; 26(7):893-901. PubMed ID: 14655926
[TBL] [Abstract][Full Text] [Related]
25. Pharmacotherapies for sleep disturbances in Alzheimer's disease.
McCleery J; Cohen DA; Sharpley AL
Cochrane Database Syst Rev; 2014 Mar; (3):CD009178. PubMed ID: 24659320
[TBL] [Abstract][Full Text] [Related]
26. Pharmacotherapies for sleep disturbances in dementia.
McCleery J; Sharpley AL
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD009178. PubMed ID: 33189083
[TBL] [Abstract][Full Text] [Related]
27. The therapeutic or prophylactic effect of exogenous melatonin against depression and depressive symptoms: a systematic review and meta-analysis.
Hansen MV; Danielsen AK; Hageman I; Rosenberg J; Gögenur I
Eur Neuropsychopharmacol; 2014 Nov; 24(11):1719-28. PubMed ID: 25224106
[TBL] [Abstract][Full Text] [Related]
28. Melatonin for the treatment of sleep disturbances in major depressive disorder.
Dolberg OT; Hirschmann S; Grunhaus L
Am J Psychiatry; 1998 Aug; 155(8):1119-21. PubMed ID: 9699707
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of Melatonin for Sleep Disturbance in Children with Persistent Post-Concussion Symptoms: Secondary Analysis of a Randomized Controlled Trial.
Barlow KM; Kirk V; Brooks B; Esser MJ; Yeates KO; Zemek R; Kirton A; Mikrogianakis A; MacMaster F; Nettel-Aguirre A; Hutchison J; Turley B; Cameron C; Hill M; Boyd R; Dewey D
J Neurotrauma; 2021 Apr; 38(8):950-959. PubMed ID: 32988292
[TBL] [Abstract][Full Text] [Related]
30. A double-blind randomized controlled trial to assess the effect of bright light therapy on depression in patients with Parkinson's disease.
Rutten S; Vriend C; Smit JH; Berendse HW; Hoogendoorn AW; van den Heuvel OA; van der Werf YD
BMC Psychiatry; 2016 Oct; 16(1):355. PubMed ID: 27769202
[TBL] [Abstract][Full Text] [Related]
31. Study of Exogenous Melatonin as a Treatment Modality for Sleep and Psychiatric Disorders in Hemodialysis Patients.
Yousef EA; El Wasify MA; Baddor AA; Sobh MA
Saudi J Kidney Dis Transpl; 2022; 33(1):1-15. PubMed ID: 36647974
[TBL] [Abstract][Full Text] [Related]
32. The use of melatonin in adult psychiatric disorders: Expert recommendations by the French institute of medical research on sleep (SFRMS).
Geoffroy PA; Micoulaud Franchi JA; Lopez R; Schroder CM;
Encephale; 2019 Nov; 45(5):413-423. PubMed ID: 31248601
[TBL] [Abstract][Full Text] [Related]
33. Circadian reinforcement therapy in combination with electronic self-monitoring to facilitate a safe post-discharge period of patients with depression by stabilizing sleep: protocol of a randomized controlled trial.
Dunker Svendsen S; Aggestrup AS; Nørregaard LB; Løventoft P; Præstegaard A; Danilenko KV; Frost M; Knorr U; Hageman I; Vedel Kessing L; Martiny K
BMC Psychiatry; 2019 Apr; 19(1):124. PubMed ID: 31023274
[TBL] [Abstract][Full Text] [Related]
34. Short-term influence of cataract surgery on circadian biological rhythm and related health outcomes (CLOCK-IOL trial): study protocol for a randomized controlled trial.
Saeki K; Obayashi K; Nishi T; Miyata K; Maruoka S; Ueda T; Okamoto M; Hasegawa T; Matsuura T; Tone N; Ogata N; Kurumatani N
Trials; 2014 Dec; 15():514. PubMed ID: 25547247
[TBL] [Abstract][Full Text] [Related]
35. Effects of chronotherapy on circadian rhythm and ADHD symptoms in adults with attention-deficit/hyperactivity disorder and delayed sleep phase syndrome: a randomized clinical trial.
van Andel E; Bijlenga D; Vogel SWN; Beekman ATF; Kooij JJS
Chronobiol Int; 2021 Feb; 38(2):260-269. PubMed ID: 33121289
[TBL] [Abstract][Full Text] [Related]
36. The SSRI citalopram increases the sensitivity of the human circadian system to light in an acute dose.
McGlashan EM; Nandam LS; Vidafar P; Mansfield DR; Rajaratnam SMW; Cain SW
Psychopharmacology (Berl); 2018 Nov; 235(11):3201-3209. PubMed ID: 30219986
[TBL] [Abstract][Full Text] [Related]
37. Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease.
Gehrman PR; Connor DJ; Martin JL; Shochat T; Corey-Bloom J; Ancoli-Israel S
Am J Geriatr Psychiatry; 2009 Feb; 17(2):166-9. PubMed ID: 19155748
[TBL] [Abstract][Full Text] [Related]
38. Use of melatonin in the treatment of phase shift and sleep disorders.
Skene DJ; Lockley SW; Arendt J
Adv Exp Med Biol; 1999; 467():79-84. PubMed ID: 10721041
[TBL] [Abstract][Full Text] [Related]
39. Bidirectional communication between sleep and circadian rhythms and its implications for depression: lessons from agomelatine.
Pandi-Perumal SR; Moscovitch A; Srinivasan V; Spence DW; Cardinali DP; Brown GM
Prog Neurobiol; 2009 Aug; 88(4):264-71. PubMed ID: 19454302
[TBL] [Abstract][Full Text] [Related]
40. Treatment of circadian rhythm disorders--melatonin.
Arendt J; Deacon S
Chronobiol Int; 1997 Mar; 14(2):185-204. PubMed ID: 9095378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
